In this context, it is essential to conduct further studies to assess the impact of the S protein on each pathophysiological mechanism related to LC, as well as the specific molecular mechanisms by which the S protein may influence clinical outcomes. The gene discussed is PROS1; the disease is laryngotracheoesophageal cleft.